~9 spots leftby Mar 2026

Fetoscopic Umbilical Cord Repair for Spina Bifida

Recruiting in Palo Alto (17 mi)
Overseen byRamesha Papanna, MD, MPH
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: The University of Texas Health Science Center, Houston
No Placebo Group

Trial Summary

What is the purpose of this trial?To fetoscopically use cryopreserved human umbilical cord allografts, named NEOX Cord 1K®, as a spinal cord cover of spina bifida defects. This procedure will be performed to create a watertight seal covering over the spinal cord in order to decrease the incidence rates of postnatal morbidities. For larger skin defects, NEOX Cord 1K® may be used as a skin cover.

Eligibility Criteria

This trial is for pregnant women over 18 with a single pregnancy, carrying fetuses with spina bifida but no other major unrelated anomalies or kyphosis. The fetus must have a normal karyotype and the defect between T1 to S1 vertebral levels. Women must be within a specific gestational age range, have no significant health risks or previous preterm deliveries, and BMI under 40 kg/m2.

Inclusion Criteria

You do not have any factors that could increase the risk of having a baby born too early.
I am 18 years old or older.
The baby does not have a curved spine.
+9 more

Exclusion Criteria

I am HIV or Hepatitis-B positive.
The placenta is in the wrong place or there is bleeding behind the placenta during pregnancy.
If you are pregnant, your cervix is shorter than 20 millimeters.
+21 more

Participant Groups

The trial tests the use of NEOX Cord 1K®, cryopreserved human umbilical cord allografts, applied via fetoscopy as a cover for spina bifida defects in fetuses. It aims to create a watertight seal on the spinal cord to reduce postnatal complications and may also serve as skin cover for larger defects.
1Treatment groups
Experimental Treatment
Group I: NEOX Cord 1K applied fetoscopicallyExperimental Treatment1 Intervention
Patients intending to undergo open in-utero spina bifida repair, will be offered to be screened for an alternative minimally invasive approach. All eligible pregnant mothers' fetuses within the trial will receive NEOX Cord 1K® as a spinal cord cover to close the developmental defect. In some cases, at the discretion of the Neurosurgeon, NEOX Cord 1K® may be required to cover the skin. All eligible subjects meeting all inclusion criteria but none of the exclusion criteria may be enrolled.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
The University of Texas Health Science Center at HoustonHouston, TX
Loading ...

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, HoustonLead Sponsor

References